A photo of Amy Shah.

Amy S. Shah, MD, MS, FNLA


  • Director, Division of Endocrinology
  • Director, Adolescent Type 2 Diabetes Program
  • Director, Research Operations, Endocrinology
  • Associate Program Director, BMCP T32 Training Grant
  • Professor, UC Department of Pediatrics

About

Biography

My interest in pediatric medicine began with the idea that diseases can be prevented and managed in childhood to avoid complications as adults. My career and research now focus on the complications of chronic diseases that begin in childhood. Type 2 diabetes, cholesterol issues and blood pressure problems, once thought to be adult diseases, are also seen more and more often in young people.

Currently, my research focuses on prevention of diabetes and if diabetes develops, its long-term health consequences. With my work, I try to determine how diabetes may impact the heart, brain and blood vessels. I hope to understand how to prevent diabetes in adolescents and reduce health problems in the future.

I serve as the director of the Adolescent Type 2 Diabetes Program at Cincinnati Children’s Hospital Medical Center. In this setting, my colleagues and I work as a team to discover the best medical and surgical treatments for youth with Type 2 diabetes. We have a comprehensive clinical team that includes gastroenterologists to assess for fatty liver disease, psychologists, nutritionists, certified diabetes educators and social workers. We also work with the bariatric surgery team to understand how bariatric surgery effects youth-onset Type 2 diabetes and its complications.

I have received several awards and honors, including:

  • 2014 Young Investigator Award, The International Society of Pediatric and Adolescent Diabetes
  • 2015 and 2016 Young Investigator Award, The National Lipid Association
  • 2016 Young Physician Scientist Award, The American Society of Clinical Investigation
  • 2016 Early Career Development Award, The Central Society for Clinical and Translational Research
  • 2020 Nominated as a Fellow of the National Lipid Association

BA: Biology, The University of Texas at Austin, Austin, TX, 2000. 

MD: St. George’s University Medical School, Grenada, West Indies, 2004.

Pediatric Residency: Loyola University Medical Center, Maywood, IL, 2007.

Endocrine Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

Research Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2011.

MS: Clinical Research, The University of Cincinnati, Cincinnati, OH, 2011.

Certifications: The American Board of Pediatrics, Subspeciality Board in Pediatric Endocrinology, Clinical Lipidology.

Interests

Type 2 diabetes; obesity; primary and secondary lipid disorders; hypertension; general endocrinology

Interests

Type 2 diabetes; type 1 diabetes; cardiovascular risk factors; lipids and lipoproteins

Research Areas

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis. Patel, D; Shah, AS; Magella, B; Bahrainian, M; Brown, EA; Liu, TY A; Shah, V; Channa, R; Wolf, RM. Journal of Diabetes and Its Complications. 2025; 39:109091.

Effect of pitavastatin on the plasma lipidome in adolescents with combined dyslipidemia. Mietus-Snyder, M; Arslanian, S; Ware, A; Urbina, E; Baker-Smith, C; Brydges, C; Fiehn, O; Cartoski, M; Freemon, D; Mahle, W; Shustak, R; Zachariah, J; De Ferranti, S; Mccrindle, B. Atherosclerosis. 2025; 407:119634.

Evaluating behavioral goals for eating timing, frequency, and distribution of daily carbohydrate consumption among youth with type 1 diabetes (MyPlan): A single arm pilot and feasibility study. Sarteau, AC; Couch, S; Kosorok, MR; Gordon-Larsen, P; Poole, C; Shah, A; Smart, C; Mayer-Davis, E. Diabetes Research and Clinical Practice. 2025; 226:112321.

916-P: Real-World Use of Sodium–Glucose Transporter 2 Inhibitors among Youth with Type 2 Diabetes. TIMKOVSKI, M; WOLF, RM; PATEL, D; MAGELLA, B; BROWN, EA; SHAH, AS. Diabetes. 2025; 74.

1165-P: Glycemic Normalization following Vertical Sleeve Gastrectomy (VSG) in Youth with Type 2 Diabetes (T2D). SEGEV, NR; NADEAU, KJ; KELSEY, MM; SCHAAF, LR; BAUMGARTNER, AM Y; RIEGLER, A; WIITALA, K; JENKINS, TM; XANTHAKOS, S; HELMRATH, M; INGE, T; SHAH, AS. Diabetes. 2025; 74.

1180-P: Regional Grey Matter Volume and Brain Function in Obese Youth with and without Type 2 Diabetes. BRADY, R; SHAH, AS; DIFRANCESCO, MW. Diabetes. 2025; 74.

1182-P: Cognitive Function in Adolescents with Type 2 Diabetes—Distinguishing Diabetes vs. Obesity. SHAH, AS; BEEBE, D; BRADY, R; RUSK, S; ALTAYE, M; DIFRANCESCO, MW. Diabetes. 2025; 74.

The relationship between brain perfusion and structure in youth with obesity, with and without type 2 diabetes: A pilot study. Brady, RP; Shah, AS; Altaye, M; Redel, JM; Beebe, DW; DiFrancesco, MW. NeuroImage-Clinical. 2025; 47:103828.

Islet Autoantibodies and Their Association With β-Cell Function and Diabetes Measures in Children With Acute Recurrent and Chronic Pancreatitis. Ginzburg, G; Hornung, L; Denson, L; Shah, AS; Swauger, S; Tatum, J; Tellez, S; Elder, D; Bellin, MD; Abu-El-Haija, M. Diabetes Care. 2025; 48:974-981.

Genetic variants and characterization of MODY in a single, large pediatric referral center. Deng, L; Shah, AS; Krishnamurthy, M. Journal of Clinical and Translational Endocrinology. 2025; 40:100398.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...